PRK introns emerge as compact expression boosters in Chlamydomonas
Reliable nuclear transgene expression remains a stubborn bottleneck in Chlamydomonas reinhardtii, even as the organism attracts sustained interest as a photosynthetic chassis for synthetic biology. This preprint takes aim at one of the most practical levers available to molecular engineers: intron-mediated enhancement. By comparing endogenous PRK introns with the widely used RBCS2i1 benchmark, the study shows that the first two PRK introns can act as modular tools for stronger transgene output across different constructs and genetic contexts.
The logic is straightforward and biologically credible. Intron retention or strategic intron placement can improve transcript accumulation, processing, export, or translation efficiency, and those effects often become decisive in organisms where foreign coding sequences are poorly expressed without help. Here, the authors focused on the phosphoribulokinase gene because previous work had already suggested that genomic sequences retaining endogenous introns behaved better than intronless counterparts. Rather than treating introns as passive sequence baggage, the study evaluates them as functional expression elements that can be swapped, benchmarked, and reused.
The result is not a minor optimization. In the tested systems, PRK introns produced enhancements reaching up to 35-fold versus intronless counterparts.
Two PRK introns consistently outperformed the baseline element
The comparison centered on the first two introns of PRK, which emerged as the strongest candidates in the set. Their activity was measured against RBCS2i1, a reference intron commonly used in Chlamydomonas engineering. Instead of relying on a single promoter or a single reporter, the work examined the introns across two reporter systems, two genetic backgrounds, and multiple promoter-terminator combinations. That design matters because intron performance in algae is rarely universal; context can alter the size of the effect, and modular tools only become useful when they hold up across varied constructs.
Across those combinations, PRK intron 1 and PRK intron 2 repeatedly showed strong intron-mediated enhancement. The consistency across reporters and backgrounds suggests these introns are not just a curiosity attached to one construct architecture. They function as reusable parts that can be inserted into different expression cassettes without collapsing into background-specific behavior. For teams building libraries of engineered strains, that kind of portability has direct value because it reduces the trial-and-error burden that often slows strain optimization.
One sentence captures the practical edge here: PRKi1 and PRKi2 are not merely introns, they are expression modules.
Patchoulol synthase exposed the difference between adequate and insufficient enhancement
The most persuasive validation came from a difficult transgene: patchoulol synthase. This enzyme is linked to production of the high-value sesquiterpene patchoulol, a target of biotechnological interest, but its expression in Chlamydomonas depends heavily on intron support. In this context, PRKi1 enabled detectable patchoulol production under conditions where a single RBCS2i1 intron was not enough.
That comparison is revealing because it moves beyond reporter readouts into a functional biosynthetic output. Detectable product formation means the expression cassette crossed a threshold that matters for pathway engineering, not just fluorescence or transcript abundance. For metabolic engineering, the key challenge is often not whether a gene can be inserted, but whether it can be expressed at a level that shifts flux into the desired compound. Here, intron choice influenced whether the pathway produced a measurable end product at all.
The implication is direct for synthetic biology workflows. If a construct stalls below the detection threshold, no amount of downstream pathway tuning can compensate. In that sense, PRKi1 changed the practical ceiling on what a single transgene could achieve in this system.
Why endogenous introns can matter so much in algal engineering
The biology behind intron-mediated enhancement is still being worked out in detail, but the effect is familiar enough to engineers: endogenous introns often outperform intronless designs because they are recognized efficiently by the host’s splicing machinery and may promote better transcript maturation. In a nuclear expression system such as Chlamydomonas, that can translate into more abundant mature mRNA and better protein yield. The organism’s native gene architecture appears to provide cues that foreign constructs lack, and introns are one way to restore those cues.
The choice of PRK introns also fits the broader logic of using host-derived sequence elements rather than generic inserts. A host’s own introns are more likely to align with its splicing preferences, sequence composition constraints, and transcript-processing machinery. This is especially relevant in a photosynthetic microalga where expression variability has long complicated strain design. The study does not claim that a single intron solves every expression problem, but it does show that some endogenous introns can function as dependable enhancement parts when benchmarked against an established standard.
The modularity angle is equally important. Compatibility with MoClo-style assembly and Biofoundry-oriented workflows means the introns can be incorporated into standardized construction pipelines. That reduces friction for scale-up, library construction, and iterative optimization, which are central to modern synthetic biology programs.
A practical toolkit for construct design, with clear limits still ahead
For algae engineers, the message is concrete: PRKi1 and PRKi2 expand the menu of sequence elements available to stabilize and strengthen nuclear transgene expression. Their performance across reporters, genetic backgrounds, and promoter-terminator pairs supports their use as modular intronic enhancers rather than one-off sequence artifacts. The patchoulol synthase result further shows that the benefit is not confined to abstract expression metrics; it can determine whether a valuable metabolite becomes detectable at all.
The study is still a preprint and has not undergone peer review, so the findings should be treated as strong but preliminary. The work also focuses on Chlamydomonas and on a defined set of construct contexts, which means performance in other hosts or more complex pathways will need separate confirmation. Even so, the data define a clear engineering direction: endogenous PRK introns deserve a place alongside the field’s standard intronic tools, especially when expression is fragile and product detection depends on crossing a narrow threshold.